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Background: The present study was carried out to evaluate antioxidant, antinociceptive and anti-inflammatory
activities of essential oil from R. maritima (RMO) in experimental protocols.
Methods: The essential oil from the roots and rhizomes of RMO were obtained by hydrodistillation using a
Clevenger apparatus, and analyzed by gas chromatography/mass spectrometry (GC/MS). Here, we evaluated free
radical scavenging activities and antioxidant potential of RMO using in vitro assays for scavenging activity against
hydroxyl radicals, hydrogen peroxide, superoxide radicals, and nitric oxide. The total reactive antioxidant potential
(TRAP) and total antioxidant reactivity (TAR) indexes and in vitro lipoperoxidation were also evaluated. The ability of
RMO to prevent lipid peroxidation was measured by quantifying thiobarbituric acid-reactive substances (TBARS). NO
radical generated at physiological pH was found to be inhibited by RMO, that showed scavenging effect upon
SNP-induced NO production at all concentrations. Antinociceptive and anti-inflammatory properties were evaluated
by acetic acid writhing reflex, Formalin-induced nociception and Carrageenan-induced edema test.
Results: The majors compounds identified was remirol (43.2%), cyperene (13.8%), iso-evodionol (5.8%), cyperotundone
(5.7%), caryophyllene oxide (4.9%), and rotundene (4.6%). At the TRAP assay, RMO concentration of 1 mg.mL−1 showed
anti-oxidant effects and at concentration of 1 and 10 ng.mL−1 RMO showed pro-oxidant effect. RMO at 1 mg.mL−1 also
showed significant anti-oxidant capacity in TAR measurement. Concentrations of RMO from 1 ng.mL−1 to 100 μg.mL−1
enhanced the AAPH-induced lipoperoxidation. RMO reduced deoxyribose oxidative damage, induced by the Fenton
reaction induction system, at concentrations from 1 ng.mL−1 to 100 μg.mL−1. We observed that RMO caused a
significant increase in rate of adrenaline auto-oxidation. On the other hand RMO did not present any scavenging
effect in H2O2 formation in vitro. The results of this study revealed that RMO has both peripheral and central
analgesic properties. The RMO, all doses, orally (p.o.) administered significantly inhibited (p < 0.05, p < 0.01 and
p < 0.001) the acetic acid-induced writhings and two phases of formalin-induced nociception in mice.
Conclusion: The RMO demonstrated antioxidant and analgesic profile which may be related to the composition of the oil.
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The use of plants as a source of products for the treatment
of diseases that affect mankind dates back to ancient ages.
However, there are few plant species present in the litera-
ture with specifications for assessing the quality of the ori-
ginating raw materials as well as validation methods that
can be used for quantification of chemical markers which is
essential for guaranteeing the efficacy and safety of the de-
rived products [1]. In the last decades, the essential oils and
various extracts of plants have been of great interest as they
have been the sources of natural products [2].
Essential oils are mixture of volatile compounds (mainly
mono- and sesquiterpenoids, benzenoids, amino acid- de-
rivatives, phenypropanoids, etc.) with biological function
on humans, animals, and other plants [3]. Nowadays, es-
sential oils are not only popular as ingredients of perfumes,
cosmetics, household cleaning products, foods and bever-
ages, but because of its medicinal applications they have
become useful in the treatment of different diseases due to
their anticancer, anticonvulsant, anti-inflammatory, anti-
microbial, analgesic, and antioxidant properties [4].
In recent years, there is an increasing interest in find-
ing antioxidant phytochemicals, because they can inhibit
the propagation of free radical reactions, protect the hu-
man body from diseases [5] and retard lipid oxidative
rancidity in foods [6]. Free radicals and other reactive
oxygen species (ROS), such as superoxide anion, hy-
droxyl radical, and hydrogen peroxide are an entire class
of highly reactive molecules derived from the normal
metabolism of oxygen or from exogenous factors and
agents. Oxidative damage to crucial cellular molecules
induced by ROS has been implicated as a possible factor
in the etiology of several human diseases, including can-
cer, cardiovascular disease, and aging [7]. Another ap-
proach to natural product with antioxidant property is
study in pain models [8].
In this context, plants have attracted the interest of
many researchers and the pharmaceutical industry itself
for being able to produce, transform, and accumulate
numerous other substances, not necessarily directly re-
lated to the maintenance of cellular metabolism, called
secondary metabolites [9]. Among the plants with prom-
ising biological activities based on the traditional use by
the population, Remirea maritima Aubl. stands out,
though studies involving this species are scarce in
current literature. R. maritima Aubl. [Syn. Mariscus ped-
unculatus (R. Br.) T. Koyama] is a tropical Cyperaceae
species popularly known as “capim-da-praia”, which has
been used traditionally to treat diarrhea, kidney disease,
high fever, pain, and inflammations [10].
Previous reports on R. maritima include the isolation
of flavones glycosides, cyperaquinones and phenolic
ketones from the roots and rhizomes of the Cyperaceae
[10-13], besides their antimicrobial activity of thedihydrocyperaquinone [12] and anti-inflammatory activity
of the essential oil and the remirol [11]. Recently, we have
shown that the aqueous extract of R. maritima features
consistent analgesic and anti-inflammatory effects [13].
However, little is known through scientific literature about
the pharmacological effects of the oil of this plant. In this
sense, the study aimed to evaluate antioxidant, antinoci-
ceptive and anti-inflammatory activities of essential oil
from R. maritima (RMO) in experimental protocols.
Methods
Plant material
R.maritima was collected in Pirambu city, Sergipe State,
Brazil (10°55´S, 35°6´W), and was identified by Dr. Ana
Paula do Nascimento Prata (a plant taxonomist of the
Department of Biology of the Federal University of Ser-
gipe, São Cristovão, SE, Brazil). A voucher specimen has
been deposited in the Herbarium of the Federal Univer-
sity of Sergipe (ASE/UFS) under No 19013.The plant
was collected in October 2010 and extracted few hours
after collection.
Hydrodistillation of the rhizomes and roots
The essential oil from fresh roots and rhizomes of R.
maritima (420 g) was obtained by hydrodistillation for
8 h using a Clevenger-type apparatus according to Siani
et al. [11]. The RMO was dried over anhydrous sodium
sulphate and the percentage content was calculated on the
basis of the weight of plant material (317.5 mg). The
essential oil was stored in a freezer until GC/MS analysis.
GC/MS analysis
GC/MS analyses were performed on a Shimadzu QP5050A
GC/MS system equipped with an AOC-20i auto-injector. A
J&W Scientific DB-5MS (coated with 5%-phenyl-95%-
dimethylpolysiloxane) fused capillary column (30 m ×
0.25 mm × 0.25 μm film thickness) was used as the station-
ary phase. Helium was the carrier gas at 1.2 mL.min−1 flow
rate. Column temperatures were programmed from 40°C
for 4 min, raised to 220°C at 4°C.min−1, and then heated to
240°C at 20°C. min−1. The injector and detector tempera-
tures were 250°C and 280°C, respectively. Samples (1.0 μL
in ethyl acetate) were injected with a 1:20 split ratio. MS
was taken at 70 eV with a scan interval of 0.5 s and frag-
ments from 40–350 Da. The retention indices [14] were
obtained by co-injecting the oil sample with a C9-C18 linear
hydrocarbon mixture (retention index from 1800–2100
range was obtained by extrapolation). The percentage com-
position of each component was determined by dividing
the area of the componentby the total area of all compo-
nents isolated under these conditions.
The volatile components were analyzed by GC/MS,
and identification was made on the basis of standard
compounds co-injection and comparison of retention
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as well as by computerized matching of the acquired
mass spectra with those stored in the NIST and Wiley
mass spectral library of the GC/MS data system and
other published mass spectra.
Isolation and identification of major compounds of the
essential oil
Part of the crude essential oil (120 mg) from R. maritima
was purified by preparative thin-layer chromatography
(TLC) with hexane-EtOAc (95:5, v/v) as the mobile phase.
The TLC was eluted three times to yield the fraction 1
(iso-evodionol (7.4 mg), fraction 2 (remirol, 15.0 mg) and
fraction 3 (cyperotundone, 2.0 mg). Fractions 1–3 were
analyzed by GC/MS and also by 1H and 13C NMR spec-
troscopy on a BRUKER DRX 400 device using CDCl3 as a
solvent and TMS as an internal standard.
Total reactive antioxidant potential (TRAP) and total
antioxidant reactivity (TAR)
The total reactive antioxidant potential (TRAP) is
employed to estimate the antioxidant capacity of sam-
ples in vitro. This method is based on the quenching of
luminol-enhanced chemiluminescence (CL) derived from
the thermolysis of 2,2´-azobis (2-amidinopropane) dihy-
drochloride (AAPH) as the free radical source [16].
The background CL was measured by adding 4 mL of
AAPH (10 mM) dissolved in glycine buffer (0.1 M,
pH 8.6) to a glass scintillation vial. Then, 10 μL of luminol
(4 mM) was added to each vial, and the CL was measured
until constant light intensity. After this stabilization time,
10 μL of Trolox solution or 10 μL of sample was added,
and the CL was measured in a liquid scintillator counter
working in the out of coincidence mode. The AUC was
calculated using Graph Pad Prism software.
Thiobarbituric acid reactive species (TBARS)
TBARS (thiobarbituric acid reactive species) assay was
employed to quantify lipid peroxidation [17] and an
adapted TBARS method was used to measure the antioxi-
dant capacity of samples using egg yolk homogenate as
lipid rich substrate [18]. Briefly, egg yolk was homoge-
nized (1% w/v) in 20 mM phosphate buffer (pH 7.4); 1 mL
of homogenate was sonicated and then homogenized with
0.1 mL of sample at different concentrations. Lipid peroxi-
dation was induced by addition of 0.1 mL of AAPH solu-
tion (0.12 M). Control was incubation medium without
AAPH. Reactions were carried out for 30 min at 37°C.
Samples (0.5 mL) were centrifuged with 0.5 mL of
trichloroacetic acid (15%) at 1200 g for 10 min. An
aliquot of 0.5 mL from supernatant was mixed with
0.5 mL TBA (0.67%) and heated at 95°C for 30 min. After
cooling, samples absorbance was measured using a spec-
trophotometer at 532 nm. The results were expressed aspercentage of TBARS formed by AAPH alone (induced
control).
Nitric oxide (.NO) scavenging assay
Nitric Oxide (NO) scavenging was generated from
spontaneous decompositions of sodium nitroprusside
in 20 mM phosphate buffer (pH 7.4). After incubation
of the NO production system, Griess reagent was added
and incubated for another 15 min. The absorbance at
540 nm was determined by spectrophotometer [19].
Hydroxyl radical (.OH) scavenging assay
Hydroxyl radicals were generated by a Fenton system
(FeSO2-H2O2). When exposed to hydroxyl radicals, the
sugar deoxyribose (DR) is degraded to malonaldehyde,
which generates a pink chromogen on heating with
thiobarbituric acid (TBA) at low pH. The method for de-
termining the scavenging of hydroxyl radicals was per-
formed according to a previously described procedure [20].
Superoxide and hydrogen peroxide-scavenging activities
(SOD/CAT-like activities)
Superoxide radical scavenging based on generation of super-
oxide radical (O−2) in the presence of NBT (0.24 mM),
glycine buffer (50 mM), EDTA (0.1 mM), and (pH 10.2) is
compared with the effect of the compounds tested [21].
Catalase-like activity was determined by the concen-
tration of H2O2 (0.02 mM) in phosphate buffer (pH 7.0)
with absorbance at 240 nm, following the method based
on Aebi [22].
In vivo experiments
Animals. Male Swiss mice (25–30 g) were kept in a
controlled-temperature room (mean temperature – stand-
ard deviation, 21°C – 2°C) with light/dark cycles of
12 hours each and were allowed free access to food
(Purina chow) and water. Experimental protocols and
procedures were approved by the Federal University of
Sergipe Animal Care and Use Committee (no. 56/09).
Acetic acid writhing reflex test
This study was performed according to Koster et al. [23].
Mice (n = 8, per group) were pretreated with RMO
(50, 100 or 200 mg.kg−1, p.o.), acetylsalicylic acid (Aspirin,
200 mg.kg−1), and the vehicle (saline + Tween-80 0.2%) by
oral route (p.o.). Then, after1 h, the mice received the
0.85% acetic acid injection (i.p.). The writhing was
counted for 15 min after a latency period of 5 min.
Formalin-induced nociception test
The procedure described by Hunskaar and Hole [24] was
used. Nociception was induced by injecting 20 μl of 1%
formalin in distilled water in the subplantar of the right-
hind paw. Mice (n = 8, per group) previously received
Table 1 Essential oil composition of R. maritima
Compound aRIcalc.
bRI % Peak area
1 1,8-cineole 1030 1026 0.2
2 silphiperfol-4,7(14)-diene 1363 1358 0.8
3 α-copaene 1375 1374 0.8
4 β-elemene 1390 1389 2.3
5 cyperene 1405 1398 13.8
6 (E)-caryophyllene 1419 1417 0.8
7 aromadendrene 1447 1439 0.6
8 α-humulene 1456 1452 0.3
9 rotundene 1462 1457 4.6
10 γ-gurjunene 1474 1475 0.9
11 trans-cadina-1(6),4-diene 1477 1476 0.8
12 β-selinene 1489 1489 0.3
13 germacrene A 1504 1504 0.3
14 δ-cadinene 1517 1522 0.3
15 α-bulnesene 1504 1509 0.3
16 α-agarofuran 1536 1537 1.9
17 guaia-6,9-dien-4β-ol 1567 1565 0.4
18 acora-3,5-dien-11-ol 1574 1574 0.5
19 caryophyllene oxide 1583 1582 4.9
20 humulene epoxide II 1610 1608 0.9
21 acora-2,4(15)-dien-11-ol 1613 1616 0.5
22 caryophylla-2(12),6-dien-5β-ol 1633 1633 0.5
23 cedr-8(15)-en-10-ol 1651 1652 0.4
24 selin-11-en-4α-ol 1659 1658 0.5
25 14-hydroxy-9-epi-(E)-caryophyllene 1970 1668 0.5
26 mustakone 1674 1676 0.4
27 germacra-4(15),5,10(14)-trien-1α-ol 1690 1685 0.6
28 cyperotundone 1698 1695d 5.7
29 14-hydroxy-humulene 1719 1713 0.7
30 6-isopropenyl-4,8a-dimethyl-
3,5,6,7,8,8a-hexahydro-2(1H)-
naphtalenone
1789 1790 0.5
31 iso-evodionol 1991 1962c,d 5.8
32 remirol 2047 2046c,d 43.2
Monoterpenes 0.2
Sesquiterpenes 45.8
Benzenoids 49.0
Total Identified Compounds 95.0
aRIcalc., retention indices on DB-5MS column calculated according to ref.
[14].bRI, retention indices according to ref. [15]. cretention index according to
ref. [11]. dco-injection with authentic standard.
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and vehicle 1 h prior to injecting formalin. These mice
were individually placed in a transparent plexiglass cage
observation chamber (25 cm× 15 cm× 15 cm). The
amount of time spent licking the injected paw was indi-
cative of pain. The number of lickings from 0 to 5 min
(early phase) and 15 to 30 min (late phase) were
counted after injection of formalin [24].
Evaluation of the motor activity
Initially, the mice able to remain on the Rota-rod appar-
atus (AVS®, Brazil) longer than 180 s (9 rpm) were se-
lected 24 h before the test [25]. Then, the selected
animals were divided into five groups (n = 8, per group)
and treated p.o. with vehicle (control) or RMO (50, 100
or 200 mg.kg−1). Each animal was tested on the rota-rod
apparatus and the time (s) they remained on the bar for
up to 180 s was recorded after 60, 120 and180 min.
Carrageenan-induced edema test
Acute hind paw edema was produced by injecting 0.05 mL
of carrageenan (1%, prepared as a suspension indistilled
water plus Tween 80 at 0.2%) locally into the sub plantar
aponeurosis of the right hind paw of mice [26]. Animals
were divided into five groups, six rats per group. RMO was
administered p.o. at different doses (50, 100, and
200 mg.kg−1), indomethacin, standard drug, (INDO,
10 mg.kg−1, p.o.), and vehicle (p.o.) was given to a
control group. RMO and INDO were administered 1 h
prior to injection of carrageenan [27]. Paw volume was
measured by dislocation of the water column of a
plethysmograph (model EFF 304, Insight®, Brazil) im-
mediately after carrageenan application (time zero)
and at 1, 2, 3, 4, 5 and 6 h after its administration.
Statistical analyses
The parameters data were evaluated by one-way ANOVA
(analysis of variance) followed by the Tukey test. Differ-
ences were considered to be statistically significant when
p < 0.05. Data were evaluated using GraphPadPrism version
5.0 (GraphPad Prism Software Inc., San Diego, CA, USA).
Results and discussion
Hydrodistillation of the rhizomes and roots of R. mari-
tima gave a yellow-orange essential oil (RMO), with a
yield of 0.08% (w/w). As shown in Table 1, it was possible
to identify 32 compounds. The major compounds identi-
fied was remirol (43.2%) as previously determined by Siani
et al. [11]. However, in this work was possible verify that
other compounds with concentration superior to 4% such
as cyperene (13.8%), iso-evodionol (5.8%), cyperotundone
(5.7%), caryophyllene oxide (4.9%), and rotundene (4.6%)
were present in the essential oil (Figure 1A and B).
Fractions 1–3 were identified by comparing their NMR(1H and 13C) (see Additional file 1) and GC/MS data
with those reported in the literature [11,28] as iso-evo-
dionol, remirol and cyperotundone, respectively. This is
Figure 1 A. GC/MS chromatogram of essential oil from roots and rhizomes of R. maritima. Peak numbers corresponding to Table 1.
B. Chemical structures of major compounds identified in the essential oil of R. maritima. Peak numbers corresponding to Table 1.
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maritima.
The TRAP and TAR methods are widely employed to es-
timate the general antioxidant capacity of samples in vitro
[29]. These methods were determined using a method
based on the quenching of luminol enhanced chemilumin-
escence derived from the thermolysis of a water-soluble azoFigure 2 Total reactive antioxidant potential (TRAP) and total antioxid
generates peroxyl radical at a constant rate, and the effect of different con
measured as area under curve during 60 min. (B) TAR values are calculated
right after RMO addition (A) and expressed as percent of inhibition. Al
mean ± SEM. ***p < 0.0001 antioxidant and # pro-oxidant effect (1-way Acompound, AAPH, used as a reliable and quantify able
source of alkyl peroxyl radicals. At the TRAP assay, RMO
concentration of 1 mg.mL−1 showed significant anti-oxidant
effects and at concentration of 1 and 10 ng.mL−1 RMO
showed pro-oxidant effect (Figure 2A). RMO at 1 mg.mL−1
also showed significant anti-oxidant capacity in TAR mea-
surement (Figure 2B).ant reactivity (TAR). (A) TRAP analysis. A free radical source (AAPH)
centrations of RMO on free radical induced chemiluminescence is
as the ratio of light intensity in absence of samples (AO)/light intensity
l groups denote samples in the presence of AAPH. Bars represent
NOVA followed by Tukey’s multiple comparison post test).
Figure 4 Nitric oxide radical scavenging activity of RMO. Values
represent mean ± standard error; experiments were performed in
triplicate. Different concentrations of the RMO were incubated along
with sodium nitroprusside. ***p < 0.001 versus sodium nitroprusside
(analysis of variance followed by Tukey test).
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damage caused by free radicals that are formed under oxi-
dative stress [30]. The ability of RMO to prevent lipid per-
oxidation was measured by quantifying thiobarbituric
acid-reactive substances (TBARS) generated by AAPH in
a lipid-rich incubation medium. The effect of different
concentrations on lipid peroxidation is shown in Figure 3.
Concentrations of RMO from 1 ng.mL−1 to 100 μg.mL−1
enhanced the AAPH-induced lipoperoxidation.
In this study, the ROM was checked for its inhibitory
effect on nitric oxide production by the method of
Griess. NO radical generated from sodium nitroprusside
at physiological pH was found to be inhibited by ROM,
that showed scavenging effect upon SNP-induced NO
production at all concentrations (Figure 4).
The hydroxyl radical–scavenging capacity of a substance
is directly related to its antioxidant activity. This radical
has the capacity to join nucleotides in DNA and cause
strand breakage, which contributes to carcinogenesis, mu-
tagenesis, and cytotoxicity [31]. We observed that the
RMO reduced deoxyribose oxidative damage, induced by
the Fenton reaction induction system, at concentrations
from 1 ng.mL−1 to 100 μg.mL−1 (Figure 5).
The capacity of RMO to interact with and/or scav-
enge/quench H2O2 and superoxide radicals and in vitro
was evaluated, respectively, by the catalase-like and the
superoxide dismutase-like reaction assays.We observed
that RMO caused a significant increase in rate of adren-
aline auto-oxidation (Figure 6). On the other hand RMO
did not present any scavenging effect in H2O2 formation
in vitro (Figure 7).Figure 3 Thiobarbituric acid-reactive substances (TBARS)
in vitro. A lipid-rich system was incubated with a free radical source
(AAPH) and the effect of different concentrations of RMO on the
lipoperoxidation was measured by quantifying TBARS. Control is
incubation medium without AAPH; other groups contained AAPH
alone or in the presence of different concentrations of RMO or its
vehicle alone. Bars represent mean ± SEM. *p < 0.05, **p < 0.0001
(1-way ANOVA followed by Tukey’s multiple comparison post test).The results of this study revealed that RMO has both
peripheral and central analgesic properties. The RMO, all
doses, orally (p.o.) administered significantly inhibited
(p < 0.05, p < 0.01 and p < 0.001) the acetic acid-induced
writhings and two phases of formalin-induced nociception
in mice (Table 2). Those effects are probably relationship
to the inhibition in the peritoneal fluid levels of PGE2 and
PGF2α [32] and with the release inhibition of substance P,
and other inflammatory molecules, such as serotonin,
histamine, bradykinin, and prostaglandins [33], respectively.
Previous studies suggested that the CNS depression and
the non-specific muscle relaxation effect can reduce the
response of motor coordination and might invalidate the
behavior tests results [34]. We find that all RMO-treatedFigure 5 Hydroxyl radical–scavenging activity of RMO. Values
represent mean ± standard error; experiments were performed in
triplicate. **p < 0.01; ***p < 0.001 versus system (analysis of variance
followed by Tukey test).
Table 2 Effect of RMO on writhing induced by acetic acid
and formalin-induced nociception tests
Treatment Dose (mg/kg) Writhing test Formalin test
Number of
writhingsa
0-5 mina 15-30 mina
Vehicle - 32.8 ± 2.8 56.3 ± 5.2 115.0 ± 8.7
RMO 50 20.6 ± 2.3b 43.0 ± 2.92 54.5 ± 4.5d
RMO 100 18.1 ± 3.6c 39.0 ± 3.0 54.8 ± 4.3d
RMO 200 10.1 ± 2.5d 31.3 ± 5.69c 38.6 ± 3.6d
Aspirin 200 3.5 ± 1.7d 40.1 ± 4.9 35.4 ± 8.9d
n = 8, per group.
aValues represent mean ± S.E.M.
bp < 0.05, cp < 0.01 and dp < 0.001 (one-way ANOVA and Tukey’s test),
significantly different from control group.
Figure 6 SOD-like activity was determined by following
formation of adrenochrome in a SOD reaction buffer containing
native purified catalase and adrenaline (O2
_ generator group).
Bars represent mean ± SEM, ***p < 0.0001 in relation to system.
One-way ANOVA followed by Tukey’s multiple comparison post test
was applied to all data.
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ation in the rota-rod apparatus (data no shown).
The initial phase of carrageenan paw edema is medi-
ated by histamine and serotonin, while the mediatorsin
the later phase are suggested to be arachidonate
metabolites (prostaglandins and leukotrienes) produ-
cing an edema dependent on the mobilization of neutro-
phils [35]. In our experiments, the edematous response
was significantly suppressed in mice pretreated with
RMO in the first phase of edema, suggesting an inhibi-
tory effect on the release of histamine and/or serotonin
(Figure 8). RMO showed a significant inhibition of
edema in the second and third phases, suggestingFigure 7 CAT-like activity was measured in a catalase reaction
buffer with H2O2. Bars represent mean ± SEM.inhibition of 5-lipoxygenase and/or cyclooxygenase, both
enzymes involved in the formation of prostaglandins and
leukotrienes [34]. This edematous response was also sig-
nificantly reduced in mice pretreated with indomethacin,
a compound known to be a cyclooxygenase inhibitor.
Some studies suggest that antinociceptive and anti-
inflammatory effects, such as induced by RMO, could
thus also be a consequence of its antioxidant ability,
which may prevent the free radical–induced nuclear
factor-κB activation and consequent pro-inflammatory
cytokines production, a cycle that perpetuates inflamma-
tory processes [30,36].
Conclusion
This is the first complete report on the analysis of the
volatile constituents from roots and rhizomes and isola-
tion of cyperotundone from R. maritima. Their antioxi-
dant activity of the oil essential of the R. maritima at
1 mg.mL−1 showed significant anti-oxidant capacity inFigure 8 Effect of RMO or indomethacin (INDO) on mice paw
edema induced by carrageenan. Mice were pretreated with
vehicle, INDO (10 mg/kg), or RMO at the doses of 50, 100, and
200 mg/kg (v.o.) 60 min before carrageenan-induced paw edema.
Measurements were performed at the times 0, 1, 2, 3, 4, 5 and 6 h
after the subplantar injection of carrageenan (1%, 50 μl). Each value
represents the mean ± S.E.M. Asterisks denote statistical significance,
*P < 0.05, **P < 0.01, and ***P < 0.001, in relation to control group.
ANOVA followed by Tukey’s test.
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concentrations of from 1 ng.mL−1 to 100 μg.mL−1, also
showing an inhibitory effect on nitric oxide production
and in reducing deoxyribose oxidative damage, at concen-
trations of 1 ng.mL−1 to 100 μg.mL−1. The antinociceptive
and anti-inflammatory activities relevant results demon-
strated the essential oil from R. maritima observed both
peripheral and central analgesic, the acetic acid-induced
writhing and two phases of formalin-induced nociception
in mice was significant at all doses (p <0.05, p <0.01 and
p <0.001), moreover the oil showed a significant inhibition
of edema in the second and third stages of the test. The
significant antioxidant activities of the essential oil con-
firm that this species is a natural source of biologically
active compounds and could thus also be a consequence
of the effects antinociceptive and anti-inflammatory of the
oil essential the R. maritima. The present study adds more
information to the ethnopharmacological knowledge of
the plant and corroborates its use in Brazil.
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